Federal Awards

Baker, Linda A, NIH-Natl Inst of DDK Diseases, Prune Belly Syndrome, $331,979; Bezprozvanny, Ilya, NIH-Natl Inst on Aging, Calcium Signaling and Synaptic maintenance in Alzheimers Disease, $484,059; Bezprozvanny, Ilya, NIH-Natl Inst of Neuro Disord & Strk, Deranged Calcium Signaling and Polyglutamine Expansion Disorders – Resubmission, $318,940; Brekken, Rolf Andrew, NIH-Natl Cancer Inst, Exploitation of RAS Signaling to Develop Therapy & Detection Strategies for PDA, $409,335; Buhrow, Leann Marie, NIH-Natl Inst of Allergy Infectious Diseases, Targeting Lipid Metabolism for the Treatment of Malaria, $60,990; Collins, James J, NIH-Natl Inst of Allergy and Infectious Diseases, The Biology of Stem Cells in the Human Parasite Schistosoma Mansoni, $405,000;

Dean, Kevin, NIH-Natl Inst of General Medical Sciences, Symmetry Breaking and Polarization of Cell in 3D Environments Con1, $61,866; DeVilbiss, Andrew Warren, NIH-Natl Cancer Inst, Role of HSF1 in Hematopoietic Stem Cell Maintenance and Function, $56,694; Fontenot, Miles R, NIH-Natl Inst of Mental Health, Neocortical Regulation of Circadian Rhythms, $31,268; Galindo, Rene Lawrence, NIH-Natl Heart, Lung and Blood Inst, T35 NHLBI Medical Student Research Training Program, $43,432; Hill, Joseph A, NIH-Natl Heart, Lund and Blood Inst, FoxO-Dependent Control of Cardiovascular Remodeling, $405,000; Holland, William L, NIH-Natl Inst of DDK Diseases, 5 R01 DK108833-02, $328,050; Hsieh, Jenny, Research Fdn of SUNY,  Circuitry Mechanisms Underlying New Neuron Development, $93,000;

Jiang, Huaqi, NIH-Natl Inst of DDK Diseases, Notch Signaling and fkh Cooperate to Maintain Intestinal Stem Cells in Drosophila, $328,050; Johnson, Romaine F, Eastern Virginia Medical School, Monitoring Juvenile Onset Recurrent Respiratory Papillomatosis – Resubmission, $34,843; Kavalali, Ege Taner, NIH-Natl Inst of Mental Health, Role of SNARE Interactions in Central Synapse Function, $357,750; Liu, Qinghua, NIH-Natl Inst of General Medical Sciences, Molecular Mechanisms of the RNAi/MicroRNA Pathways – Resubmission 1, $306,180; Makarewich, Catherine A, NIH-Natl Heart, Lung and Blood Inst, Elucidation of the Role of a Novel Cardiac Micropeptide in the Control of Heart, $57,066; Mohan, Ashwathi Sarayu, NIH-Natl Cancer Institute, The Mechanical and Biochemical Mechanism of Oncogenic Rac1P29S, $32,049; Nijhawan, Ank E, Miriam Hosp, Improving Linkage to Care Following Release, $2,514;

Ouyang, Zhiming, NIH-Natl Inst of Allergy and Infectious Diseases, Rrp2, an Atypical Bacterial Enhancer Binding Protein in Borrelia Burgdorferi, $202,500; Rogers, Zora R, St. Jude Children’s Res Hosp, Hydroxyurea Management in Kids: Intensive versus Stable Dosage Strategies” (HUG K, $40,323; Romero, Steven A, NIH-Natl Inst of General Medical Sciences, Vascular Conditioning in Burn Survivors, $57,066; Scherer, Philipp E, Yale University School of Medicine, Project 3: Impact of the FGF21-Adiponectin-Ceramide Axis on Healthspan, $327,946; Schmid, Sandra Louise, NIH-Natl Inst of Mental Health, The Clathrin Coated Vesicle Cycle, $475,570; Skapek, Stephen Xavier, Children’s Hosp of Philadelphia, Skapek – COG Phase 1 Pilot Consortium, $20,102;

Toto, Robert Daniel, Univ of Pittsburgh, University of Pittsburgh Clinical and Translational Science Institute – ACTs, $87,310; Vinogradov, Elena, NIH-Natl Inst of Biomedical Imaging, Endogenous Urea CEST MRI (urCEST): pH and Urea Gradient Mapping in Human Kidney, $218,700; Wang, Jing, NIH-Natl Inst of Biomedical Imaging,  Next Generation 4D-CBCT for Lung Cancer Radiation Therapy , $328,050; Xu, Wei, NIH-Natl Inst of Mental Health, Neuronal Mechanisms for Fear Memory Generalization in PTSD and Anxiety Disorders, $223,054; Yin, Helen Lu, NIH-Natl Inst of General Medical Sciences, PI4KIIα in Late Stage Autophagy, $384,453.

Nonfederal Awards

Fu, Qi, Amer Heart Assoc SW Affiliate, Sex Differences in Elderly Hypertension, $70,000; Hashimoto, Hisayuki, Kanae Fdn, Induction of Diverse Cardiac Cell Types by Direct Reprogramming, $8,634; Hedayati, S Susan, Univ of Washington, Treatment Options for Depression in Patients Undergoing Hemodialysis, $123,461; Holland, William L, Juvenile Diabetes Res Fdn, 2-SRA-2016-149-Q-R Yr 2, $350,000; Hsieh, Jer-Tsong, UT Dallas, Mapping Acidic Tumor Microenvironment with Renal Clearable pH Nanoindicators, $111,423; Kourrich, Said, Brain & Behavior Res Fdn/NARSAD, 2015 NARSAD Young Investigator Award, $35,000; Liu, Li, UT Dallas, Optimizing Therapeutic Strategies Against Lung Cancer Using Multi-Modality Imaging, $150,000;

Mattrey, Robert Frederick, CPRIT, RR150 010 Developing and Translating Ultrasound and Nanotechnology to Enhance Cancer Imaging, $1,200,000; Morrison, Sean Joseph, CPRIT, Mechanisms of Melanoma Metastasis, $292,762; Murphy, Caitlin, AcademyHealth, Patterns of Prescription Medication Use and Polypharmacy Among Cancer Survivors, $10,000; Olson, Eric N, Parent Project Muscular Dystrophy (PPMD), Correction of DMD Mutations by Myoediting, $262,500; Pfeiffer, Julie K, Burroughs Wellcome Fund, How Gut Microbes Enhance Enteric Virus Infectivity, $0; Scaglioni, Pier Paolo, UT M.D. Anderson Cancer Cntr, Defining and Defeating Mechanistic Subtypes of KRAS-Mutant Lung Cancers – Resubmission, $199,684; Sharma, Preeti Bhatia, Cystic Fibrosis Fdn, Mental Health Coordinator, $53,999; Sharma, Preeti Bhatia, Cystic Fibrosis Fdn, Award for Physical Therapist, $34,430;

Syed, Zubair A, Texas Higher Ed Coord Board, Texas Higher Education Coordinating (THECB) FM Program, $311,106; Winick, Naomi Joan, Children’s Hosp of Philadelphia, Home or Away from Home: Comparing Clinician and Patient/Family-Centered Outcomes, $25,008; Yu, Hongtao, Clayton Fdn for Res, Development of Next Generation Antimitotic Anticancer Drug, $300,000; Zhu, Wenhan, Crohn’s & Colitis Fdn of America, Precision Targeting Enterobacteriaceae During Gut Inflammation Ameliorates Coliti, $58,250. 

Industry Sponsored Awards, dollar amounts not available

Abu-Hijleh, Muhanned A, OncoCyte Corp, Study to Evaluate a Panel of Blood Biomarkers for use in Patients Undergoing Evaluation for Lung Cancer; Bartolome, Sonja Darrell, United Therapeutics Corp, A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial; Brown, Edson Sherwood, Otsuka America Pharmaceutical Inc, Brexpiprazole for Bipolar Depression; Danuser, Gaudenz, FEI Co, Sponsored Research Agreement OTD Contract ID 110877; Gerber, David Eric, Abbvie Inc, M14-237: A Multicenter, Phase 1/1b, Open-Label, Dose-Escalation Study of ABBV-399, an Antibody Drug Conjugate, in Subjects with Advanced Solid Tumors; Gerber, David Eric, RTOG Fdn, RTOG 3505: Randomized, Double Blinded Phase III Trial; Gupta, Olga Theresa, Astrazeneca Pharmaceuticals LP, A Phase 3 , Double-Blind, Placebo-Controlled, Randomized Trial to Assess the Safety and Efficacy of Ofexenatide in Adolescents with Type 2 Diabetes; Hammers, Hans, Bristol-Myers Squibb Co, A Phase II Trial of Stereotactic Body Radiation Therapy;

Jain, Raksha, Vertex Pharmaceuticals Inc, A Phase 2, Randomized, Double-Blind, Controlled Study to Evaluate the Safety and Efficacy of VX-440; Laetsch, Theodore W, Neuroblastoma and Medulloblastoma Trc, NMTRC 014, NMTT – Neuroblastoma Maintenance Therapy Trial; Lannaccone, Susan Theresa, Biogen Inc, Expanded Access Program (EAP) to provide Nusinersen to Patients with Infantile-Onset Spinal Muscular Atrophy (SMA); Lingvay, Ildiko, Novo Nordisk Inc, Efficacy and Safety; Lotan, Yair, Cleveland Diagnostics Inc, IsoPSA: PSA Isoforms in Peripheral Blood for More Accurate Prostate Cancer Diagnosis; Miller, David Scott, Aprea AB, PiSARRO: p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer; Miller, David Scott, Millennium Pharmaceuticals Inc, A Phase 2, Randomized Study of MLN0128 (a Dual TORC1/2 I; Shah, Trushil Gaurav, Actelion Pharmaceuticals US Inc, Uptravi® (SelexiPag): The Users Drug Registry; Siegwart, Daniel John, ReCode Therapeutics, Sponsored Research Agreement OTD Contract #111057.